HIGHLIGHTS
- who: Sunil Thomas and collaborators from the Lankenau Institute for Medical Research, Wynnewood, PA, United States of America, Lankenau Medical Editor:, University of Arkansas have published the Article: Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment, in the Journal: PLOS ONE of 29/04/2022
- what: Based on the study, the authors explored whether the Bin1 monoclonal_antibodies (mAb) developed by the laboratory phenocopied effects of genetic attenuation in the colitis model. The authors report progress in how Bin1 mAb treatment protects against DSS-induced colitis; specifically . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.